Search

Your search keyword '"Roach PJ"' showing total 321 results

Search Constraints

Start Over You searched for: Author "Roach PJ" Remove constraint Author: "Roach PJ"
321 results on '"Roach PJ"'

Search Results

4. A Prevalent Variant inPPP1R3A Impairs Glycogen Synthesis and Reduces Muscle Glycogen Content in Humans and Mice

6. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy

7. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).

8. Bowel Visualization on Bone Scan Because of Protein Losing Enteropathy

9. Osteoid osteoma: comparative utility of high-resolution planar and pinhole magnification scintigraphy

10. The value of bronchodilator administration in asthmatic patients before lung imaging

11. Arm splints seen on bone scan in a volleyball player

12. Sympathetic Denervation Due to Neuroblastoma

13. Portal vein glucose entry triggers a coordinated cellular response that potentiates hepatic glucose uptake and storage in normal but not high-fat/high-fructose-fed dogs.

14. A cyclic guanosine monophosphate-dependent pathway can regulate net hepatic glucose uptake in vivo.

18. Pulmonary emboli imaging with (99m)Tc-labelled anti-D-dimer (DI-80B3) Fab' followed by SPECT.

19. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

20. Metabolic Tumor Volume on 18-Fluorodeoxyglucose Positron Emission Tomography as a Prognostic Marker of Survival in Patients With Locally Advanced or Metastatic Neuroendocrine Neoplasms Treated With 177Lutetium-DOTA-Octreotate Peptide Receptor Radionuclide Therapy.

21. Impaired malin expression and interaction with partner proteins in Lafora disease.

23. Integration of metabolic flux with hepatic glucagon signaling and gene expression profiles in the conscious dog.

24. Small-molecule inhibition of glycogen synthase 1 for the treatment of Pompe disease and other glycogen storage disorders.

25. Integration of metabolic flux with hepatic glucagon signaling and gene expression profiles in the conscious dog.

26. Single-centre experience with peptide receptor radionuclide therapy for neuroendocrine tumours (NETs): results using a theranostic molecular imaging-guided approach.

27. 64 Cu Treatment Planning and 67 Cu Therapy with Radiolabeled [ 64 Cu/ 67 Cu]MeCOSar-Octreotate in Subjects with Unresectable Multifocal Meningioma: Initial Results for Human Imaging, Safety, Biodistribution, and Radiation Dosimetry.

28. Australasian Consensus Statement on the Identification, Prevention, and Management of Hormonal Crises in Patients with Neuroendocrine Neoplasms Undergoing Peptide Receptor Radionuclide Therapy.

29. Letter to Editor Re: "Combined Quantification of 18F-FDG and 68Ga-DOTATATE PET/CT for Prognosis in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms" (https://doi.org/10.1016/j.acra.2021.10.004).

30. The structural mechanism of human glycogen synthesis by the GYS1-GYG1 complex.

31. Computed tomography (CT)-defined sarcopenia and myosteatosis are prevalent in patients with neuroendocrine neoplasms (NENs) treated with peptide receptor radionuclide therapy (PRRT).

32. Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker.

33. Brain glycogen serves as a critical glucosamine cache required for protein glycosylation.

34. Safety and tolerability of Miltuximab ® - a first in human study in patients with advanced solid cancers.

35. GYS1 or PPP1R3C deficiency rescues murine adult polyglucosan body disease.

36. Routine Early 68Ga-DOTATATE Positron Emission Tomography Has Low Yield After Resection of Appendiceal Neuroendocrine Neoplasms.

37. Discovery and Development of Small-Molecule Inhibitors of Glycogen Synthase.

38. Accurate and sensitive quantitation of glucose and glucose phosphates derived from storage carbohydrates by mass spectrometry.

39. A Brief History of Lung Ventilation and Perfusion Imaging Over the 50-Year Tenure of the Editors of Seminars in Nuclear Medicine.

40. High Metabolic Tumour Volume on 18-Fluorodeoxyglucose Positron Emission Tomography Predicts Poor Survival from Neuroendocrine Neoplasms.

41. Glycogen Dynamics Drives Lipid Droplet Biogenesis during Brown Adipocyte Differentiation.

42. Targeting Pathogenic Lafora Bodies in Lafora Disease Using an Antibody-Enzyme Fusion.

43. Letter From the Guest Editors.

44. FET PET in the evaluation of indeterminate brain lesions on MRI: Differentiating glioma from other non-neoplastic causes - A pilot study.

45. Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastoma.

46. Lafora disease offers a unique window into neuronal glycogen metabolism.

47. The Impact of 68 Ga-PSMA PET/CT on Management Intent in Prostate Cancer: Results of an Australian Prospective Multicenter Study.

48. Lack of liver glycogen causes hepatic insulin resistance and steatosis in mice.

49. Prognostic and predictive biomarkers in neuroendocrine tumours.

50. Novel method for detection of glycogen in cells.

Catalog

Books, media, physical & digital resources